Cargando…
Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor.
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813093/ https://www.ncbi.nlm.nih.gov/pubmed/33489132 http://dx.doi.org/10.1002/ccr3.3399 |
_version_ | 1783637790279335936 |
---|---|
author | Ogata, Takatsugu Narita, Yukiya Misawa, Kazunari Hosoda, Waki Muro, Kei |
author_facet | Ogata, Takatsugu Narita, Yukiya Misawa, Kazunari Hosoda, Waki Muro, Kei |
author_sort | Ogata, Takatsugu |
collection | PubMed |
description | Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor. |
format | Online Article Text |
id | pubmed-7813093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78130932021-01-22 Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake Ogata, Takatsugu Narita, Yukiya Misawa, Kazunari Hosoda, Waki Muro, Kei Clin Case Rep Case Reports Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor. John Wiley and Sons Inc. 2020-11-18 /pmc/articles/PMC7813093/ /pubmed/33489132 http://dx.doi.org/10.1002/ccr3.3399 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Ogata, Takatsugu Narita, Yukiya Misawa, Kazunari Hosoda, Waki Muro, Kei Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title | Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title_full | Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title_fullStr | Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title_full_unstemmed | Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title_short | Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
title_sort | marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813093/ https://www.ncbi.nlm.nih.gov/pubmed/33489132 http://dx.doi.org/10.1002/ccr3.3399 |
work_keys_str_mv | AT ogatatakatsugu markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake AT naritayukiya markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake AT misawakazunari markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake AT hosodawaki markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake AT murokei markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake |